• CARDILLO, C., CAMPIA, U., BRYANT, M.B. & PANZA, J.A. (2002). Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation, 106, 17831787.
  • CARDILLO, C., NAMBI, S.S., KILCOYNE, C.M., CHOUCAIR, W.K., KATZ, A., QUON, M.J. & PANZA, J.A. (1999). Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation, 100, 820825.
  • CLARK, M.G., COLQUHOUN, E.Q., RATTIGAN, S., DORA, K.A., ELDERSHAW, T.P., HALL, J.L. & YE, J. (1995). Vascular and endocrine control of muscle metabolism. Am. J. Physiol., 268, E797E812.
  • COLQUHOUN, E.Q., HETTIARACHCHI, M., YE, J.M., RICHTER, E.A., HNIAT, A.J., RATTIGAN, S. & CLARK, M.G. (1988). Vasopressin and angiotensin II stimulate oxygen uptake in the perfused rat hindlimb. Life Sci., 43, 17471754.
  • D'ORLEANS-JUSTE, P., CLAING, A., WARNER, T.D., YANO, M. & TELEMAQUE, S. (1993). Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br. J. Pharmacol., 110, 687692.
  • DE NUCCI, G., THOMAS, R., D'ORLEANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 85, 97979800.
  • DORA, K.A., RATTIGAN, S., COLQUHOUN, E.Q. & CLARK, M.G. (1994). Aerobic muscle contraction impaired by serotonin-mediated vasoconstriction. J. Appl. Physiol., 77, 277284.
  • DORA, K.A., RICHARDS, S.M., RATTIGAN, S., COLQUHOUN, E.Q. & CLARK, M.G. (1992). Serotonin and norepinephrine vasoconstriction in rat hindlimb have different oxygen requirements. Am. J. Physiol., 262, H698H703.
  • ERINGA, E.C., STEHOUWER, C.D., MERLIJN, T., WESTERHOF, N. & SIPKEMA, P. (2002). Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovasc. Res., 56, 464471.
  • FERRI, C., CARLOMAGNO, A., COASSIN, S., BALDONCINI, R., FALDETTA, M.R.C., LAURENTI, O., PROPERZI, G., SANTUCCI, A. & DE MATTIA, G. (1995). Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care, 18, 226233.
  • IDRIS, I., PATIAG, D., GRAY, S. & DONNELLY, R. (2001). Tissue- and time-dependent effects of endothelin-1 on insulin-stimulated glucose uptake. Biochem. Pharmacol., 62, 17051708.
  • JUST, A., OLSON, A.J. & ARENDSHORST, W.J. (2004). Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors. Am. J. Physiol. Renal Physiol., 286, F660F668.
  • KEDZIERSKI, R.M. & YANAGISAWA, M. (2001). Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol., 41, 851876.
  • MAGUIRE, J.J. & DAVENPORT, A.P. (1995). ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br. J. Pharmacol., 115, 191197.
  • MATHER, K.J., MIRZAMOHAMMADI, B., LTEIF, A., STEINBERG, H.O. & BARON, A.D. (2002). Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes, 51, 35173523.
  • MCENIERY, C.M., WILKINSON, I.B., JENKINS, D.G. & WEBB, D.J. (2002). Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans. Hypertension, 40, 202206.
  • NEWMAN, J.M., DORA, K.A., RATTIGAN, S., EDWARDS, S.J., COLQUHOUN, E.Q. & CLARK, M.G. (1996). Norepinephrine and serotonin vasoconstriction in rat hindlimb control different vascular flow routes. Am. J. Physiol., 270, E689E699.
  • OTTOSSON-SEEBERGER, A., LUNDBERG, J.M., ALVESTRAND, A. & AHLBORG, G. (1997). Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol. Scand., 161, 211220.
  • PIUHOLA, J., MAKINEN, M., SZOKODI, I. & RUSKOAHO, H. (2003). Dual role of endothelin-1 via ETA and ETB receptors in regulation of cardiac contractile function in mice. Am. J. Physiol. Heart Circ. Physiol., 285, H112H118.
  • PLUSCZYK, T., BERSAL, B., MENGER, M.D. & FEIFEL, G. (2001). Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation. Dig. Dis. Sci., 46, 13431351.
  • RATTIGAN, S., DORA, K.A., COLQUHOUN, E.Q. & CLARK, M.G. (1993). Serotonin-mediated acute insulin resistance in the perfused rat hindlimb but not in incubated muscle: a role for the vascular system. Life Sci., 53, 15451555.
  • RICH, S. & MCLAUGHLIN, V.V. (2003). Endothelin receptor blockers in cardiovascular disease. Circulation, 108, 21842190.
  • RUDERMAN, N.B., HOUGHTON, C.R. & HEMS, R. (1971). Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem. J., 124, 639651.
  • VERMA, S., YAO, L., STEWART, D.J., DUMONT, A.S., ANDERSON, T.J. & MCNEILL, J.H. (2001). Endothelin antagonism uncovers Insulin-mediated vasorelaxation in vitro and in vivo. Hypertension, 37, 328333.
  • WARNER, T.D., MITCHELL, J.A., DE NUCCI, G. & VANE, J.R. (1989). Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J. Cardiovasc. Pharmacol., 13, S85S88.